Catalent, Inc. Stock price

Equities

CTLT

US1488061029

Pharmaceuticals

Delayed Nyse 04:03:36 2023-09-26 pm EDT Intraday chart for Catalent, Inc. 5-day change 1st Jan Change
45.63 USD -0.35% -3.98% +1.38%
Sales 2023 4,276 M Sales 2024 * 4,361 M Capitalization 8 226 M
Net income 2023 -232 M Net income 2024 * 9 M EV / Sales 2023
2,90x
Net Debt 2023 4,569 M Net Debt 2024 * 4,207 M EV / Sales 2024 *
2,85x
P/E ratio 2023
-33,6x
P/E ratio 2024 *
857x
Employees -
Yield 2023
-
Yield 2024 *
-
Free-Float97.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.35%
1 week-3.98%
Current month-8.69%
1 month+1.65%
3 months+4.13%
6 months-29.00%
Current year+1.38%
More quotes
1 week
44.65
Extreme 44.65
47.87
1 month
44.65
Extreme 44.65
51.79
Current year
31.45
Extreme 31.45
74.49
1 year
31.45
Extreme 31.45
81.72
3 years
31.45
Extreme 31.45
142.64
5 years
29.23
Extreme 29.23
142.64
10 years
18.92
Extreme 18.92
142.64
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 2022
Corporate Officer/Principal 47 2022
Chief Administrative Officer 61 2022
Members of the board TitleAgeSince
Director/Board Member 65 2015
Director/Board Member 70 2014
Director/Board Member 59 2015
More insiders
Date Price Change Volume
23-09-26 45.63 -0.35% 902,296
23-09-25 45.79 +0.99% 1,962,607
23-09-22 45.34 -2.60% 1,642,151
23-09-21 46.55 -3.52% 1,628,993
23-09-20 48.25 +1.54% 1,242,778

Delayed Quote Nyse, September 26, 2023 at 04:03 pm EDT

More quotes
Catalent, Inc. is specialized in pharmaceutical outsourcing services. The group offers solutions for the development and formulation of drugs, biological products and animal health products. Net sales break down by activity as follows: - subcontracted manufacturing services (48.5%) - provision of development services (43.2%); - clinical supply services (8.3%). Net sales are distributed geographically as follows: the United States (62.9%), Europe (30.5%) and other (6.6%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
45.63USD
Average target price
52.00USD
Spread / Average Target
+13.96%
Consensus
  1. Markets
  2. Equities
  3. Stock Catalent, Inc. - Nyse
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer